| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Scorpion (centruroides) immune Fab2 antivenin (equine) |
| Active Ingredient | Scorpion (centruroides) immune Fab2 antivenin (equine) |
| Brand Names | Anascorp, Acsera 5 Ml Enjeksiyonluk Cozelti Konsantresi Iceren Flakon |
| Drug Category | Pulmonology |
| Drug Class | Palliative treatment, Antidote / toxicity management, Immunosuppressive therapy |
| Dosage Forms | Injection, Injection, powder, lyophilized, for solution, Injection, solution |
| Route of Administration | Intramuscular, Intravenous, Subcutaneous |
| FDA Approval Status | FDA Approved (August 2011) Approved |
Scorpion (centruroides) immune Fab2 antivenin (equine) Overview
Scorpion (centruroides) immune Fab2 antivenin (equine) is a purified preparation of immunoglobulin gamma (IgG) F(ab’)2 fragments derived from the plasma of horses immunized against specific Centruroides scorpion venoms. Functioning biologically as an antidote and venom-neutralizing agent, it is administered to patients presenting with clinically significant signs of scorpion envenomation, such as loss of muscle control or respiratory failure. By binding directly to venom toxins, it prevents systemic toxicity and allows for the safe elimination of the venom from the patient’s body.
What Is Scorpion (centruroides) immune Fab2 antivenin (equine) and How Does It Work?
Scorpion (centruroides) immune Fab2 antivenin (equine) is a protein-based polyvalent antivenin composed of venom-specific F(ab’)2 antibody fragments. These fragments are produced by hyperimmunizing horses with the venom of several Centruroides species (including C. noxius, C. l. limpidus, C. l. tecomanus, and C. s. suffusus), followed by enzymatic cleavage of the resulting IgG antibodies to isolate the F(ab’)2 fragments, which reduces the risk of severe hypersensitivity compared to whole antibodies.
Once administered, the antivenin functions by directly circulating in the bloodstream and binding to unbound scorpion venom toxins. This neutralization process promotes the redistribution of the toxin away from critical target tissues such as the cardiovascular and neuromuscular systems and facilitates its subsequent elimination from the body, thereby reversing life-threatening neuromuscular and respiratory paralysis.
Is Scorpion (centruroides) immune Fab2 antivenin (equine) FDA Approved?
Scorpion (centruroides) immune Fab2 antivenin (equine) is approved by the United States Food and Drug Administration (FDA). It was officially approved in August 2011 under the brand name Anascorp for the clinical treatment of systemic scorpion envenomation.
What Is Scorpion (centruroides) immune Fab2 antivenin (equine) Used For?
- Used for the clinical reversal of venom poisoning caused by Centruroides scorpion stings.
- Indicated for the treatment of severe clinical signs of scorpion envenomation, including loss of muscle control, severe cardiovascular effects, and acute respiratory failure.
Before Taking Scorpion (centruroides) immune Fab2 antivenin (equine): Contraindications & Precautions
Because this medication is derived from equine (horse) plasma, there is an inherent risk of acute hypersensitivity reactions, including severe anaphylaxis and delayed serum sickness. However, because scorpion envenomation can be rapidly fatal (particularly in pediatric patients), the risks of withholding treatment must be carefully weighed against the risks of an allergic reaction.
Who Should Not Take Scorpion (centruroides) immune Fab2 antivenin (equine)?
- There are no absolute contraindications for the use of this antivenin in patients presenting with life-threatening scorpion envenomation.
- Extreme caution must be exercised in individuals with a known severe allergy to horse proteins or those who have previously experienced anaphylaxis following the administration of equine-derived antivenins.
Scorpion (centruroides) immune Fab2 antivenin (equine), Pregnancy & Fertility
Adequate, well-controlled studies regarding the safety of this antivenin in pregnant women have not been conducted. It is not known whether it can cause fetal harm when administered during pregnancy or affect reproductive capacity. However, because severe scorpion envenomation presents a critical, immediate threat to the lives of both the mother and the fetus, the antivenin is generally administered if clearly needed.
Tell Your Doctor Before Taking Scorpion (centruroides) immune Fab2 antivenin (equine)
Due to the emergency nature of administration, patients or their caregivers should immediately inform the attending critical care team of any known allergies to horses, previous treatments with antivenins (such as snakebite treatments), or a history of severe asthma, as these factors drastically increase the risk of an anaphylactic reaction.
Scorpion (centruroides) immune Fab2 antivenin (equine) Dosage & Administration
This medication is administered exclusively in an emergency department or intensive care setting by trained healthcare professionals capable of managing anaphylaxis and respiratory failure.
Standard Scorpion (centruroides) immune Fab2 antivenin (equine) Dosing
- Treatment is typically initiated with a starting dose of 3 vials, reconstituted and administered intravenously over a specific duration as outlined by the manufacturer.
- If clinical signs of envenomation persist (such as continued muscle spasms or respiratory distress), additional single-vial doses may be administered at 30-to-60-minute intervals until symptom resolution is achieved.
How Scorpion (centruroides) immune Fab2 antivenin (equine) Is Administered
- Administered primarily via continuous intravenous (IV) infusion in clinical settings (Anascorp).
- International formulations may utilize intramuscular (IM) or subcutaneous (SubQ) routes depending on the specific product labeling and clinical severity.
- The lyophilized powder must be carefully reconstituted with sterile saline prior to IV infusion.
Scorpion (centruroides) immune Fab2 antivenin (equine) Clinical Efficacy & Research
Clinical trials demonstrated that administration of this polyvalent antivenin rapidly resolves the severe neurological and neuromuscular symptoms of Centruroides envenomation. Particularly in the United States, it is highly efficacious against the venom of Centruroides sculpturatus (the Arizona bark scorpion). In heavily affected populations, particularly pediatric patients who are most vulnerable to respiratory failure from stings, prompt administration drastically reduces the need for heavy sedation and prolonged mechanical ventilation in the ICU.
Scorpion (centruroides) immune Fab2 antivenin (equine) Side Effects & Safety Profile
This medication does not currently carry an FDA Black Box Warning. However, standard warnings emphasize the constant risk of severe, life-threatening anaphylaxis during and immediately following the infusion.
While highly effective, the infusion of foreign equine proteins carries significant immunological risks, ranging from immediate acute allergic reactions to delayed systemic immune responses.
Common Scorpion (centruroides) immune Fab2 antivenin (equine) Side Effects
- Vomiting, nausea, and general gastrointestinal distress.
- Pyrexia (fever) and fatigue.
- Pruritus (itching) or localized rash.
Serious Scorpion (centruroides) immune Fab2 antivenin (equine) Adverse Events
- Immediate anaphylactic shock, characterized by severe bronchospasm, hypotension, and airway compromise.
- Serum sickness, a delayed type III hypersensitivity reaction presenting 1 to 3 weeks post-infusion with joint pain, fever, muscle aches, and rash.
Managing Scorpion (centruroides) immune Fab2 antivenin (equine) Side Effects
Intravenous epinephrine, corticosteroids, and antihistamines must be immediately available at the patient’s bedside during the entire infusion. If a severe allergic reaction occurs, the infusion must be halted instantly and emergency anaphylaxis protocols initiated. Delayed serum sickness is typically managed outpatient with oral corticosteroids and antihistamines.
Scorpion (centruroides) immune Fab2 antivenin (equine) Drug Interactions & What to Avoid
Because it acts specifically by binding to venom toxins in the bloodstream, formal drug-drug interaction studies have not been heavily documented.
Scorpion (centruroides) immune Fab2 antivenin (equine) Drug-Drug Interactions
- No specific, contraindicated drug-drug interactions are established for this antivenin.
- Concomitant use of central nervous system depressants may complicate the clinical assessment of neuromuscular and respiratory depression caused by the scorpion venom itself.
Scorpion (centruroides) immune Fab2 antivenin (equine), Food & Alcohol
Food and alcohol interactions are not clinically relevant due to the acute, emergency nature of administration in critical care settings.
Scorpion (centruroides) immune Fab2 antivenin (equine) Missed Dose, Overdose & Storage
This medication is utilized solely in acute emergency environments; therefore, traditional dosing concepts like missed daily doses do not apply.
Missed Dose of Scorpion (centruroides) immune Fab2 antivenin (equine)
If symptoms of envenomation return after the initial treatment course, the clinical team will reassess the patient and administer additional vials as medically necessary.
Scorpion (centruroides) immune Fab2 antivenin (equine) Overdose & Emergency
Overdosing on antivenin increases the total volume of foreign equine protein in the bloodstream, escalating the likelihood of severe anaphylaxis and subsequent serum sickness. Overdose management involves immediately ceasing the infusion and providing aggressive symptomatic support for hypersensitivity.
How to Store Scorpion (centruroides) immune Fab2 antivenin (equine)
Store unmixed vials at controlled room temperature (up to 25°C / 77°F). Vials must not be frozen. Once reconstituted, the solution should be used immediately or stored according to the manufacturer’s exact guidelines.
Scorpion (centruroides) immune Fab2 antivenin (equine) Patient Management & Monitoring
Critical care monitoring is absolutely mandatory during the administration of any equine-derived antivenin.
Tests Before Starting Scorpion (centruroides) immune Fab2 antivenin (equine)
- Baseline assessment of respiratory drive, blood pressure, and neuromuscular control.
- Evaluation of patient history regarding prior exposure to horse-derived immunoglobulins to stratify anaphylaxis risk.
Monitoring During Scorpion (centruroides) immune Fab2 antivenin (equine) Treatment
Patients require continuous cardiac monitoring, pulse oximetry, and frequent vital sign checks throughout the infusion. Medical staff must observe continuously for signs of acute allergic reactions, such as sudden wheezing, facial swelling, or drops in blood pressure, for at least one hour post-infusion.
Scorpion (centruroides) immune Fab2 antivenin (equine) Do’s and Don’ts
- Do proceed immediately to the nearest emergency room if you or a child are stung by a scorpion and experience muscle twitching, rapid eye movements, or difficulty breathing.
- Do monitor for fever, rash, and joint pain in the weeks following treatment, as this indicates serum sickness.
- Do not attempt to treat severe scorpion stings at home with ice, tourniquets, or over-the-counter pain relievers.
Frequently Asked Questions
What exact type of chemical is this medication?
It is a purified protein preparation consisting of F(ab’)2 fragments of immunoglobulin G (IgG) antibodies derived from the blood of horses immunized against scorpion venom.
Is this antivenin FDA approved?
Yes, it was approved by the US FDA in 2011 and is marketed under the brand name Anascorp.
What kinds of scorpions does this treat?
It is specifically designed to neutralize venom from Centruroides scorpions, including the highly dangerous Arizona bark scorpion (Centruroides sculpturatus).
Why is the medication made using horses?
Horses possess a large blood volume and mount a robust immune response to small, safe doses of venom, producing high quantities of the necessary neutralizing antibodies that can be purified for human use.
What is the biggest risk of taking this medication?
The primary risk is a severe allergic reaction (anaphylaxis) because the medication contains foreign proteins derived from horses.
What is serum sickness?
Serum sickness is a delayed allergic reaction to the horse proteins in the antivenin, typically occurring 1 to 3 weeks after leaving the hospital, characterized by fever, joint pain, and an itchy rash.
References
- DrugBank Database – Scorpion (centruroides) immune Fab2 antivenin (equine) Clinical and Pharmacological Profile
- Gemini Chat for Reviewing and Generation.md
Legal Disclaimer
The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or emergency protocols.

























